Lista de obras - Raffaella Pasquale - Dominio Público Uruguay

Activity of gefitinib in a non-small-cell lung cancer patient with both activating and resistance EGFR mutations

artículo científico publicado en 2013

Assessment of high-sensitive methods for the detection of EGFR mutations in circulating free tumor DNA from NSCLC patients

artículo científico publicado en 2015

BRAF V600E mutation in metastatic colorectal cancer: Methods of detection and correlation with clinical and pathologic features.

artículo científico publicado en 2016

Comparison of the seleno-transcriptome expression between human non-cancerous mammary epithelial cells and two human breast cancer cell lines

artículo científico publicado en 2017

Detection of EGFR mutations by TaqMan mutation detection assays powered by competitive allele-specific TaqMan PCR technology

artículo científico publicado en 2013

EGFR mutations in lung cancer: from tissue testing to liquid biopsy

artículo científico

Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma.

scientific article published on 19 July 2016

Liquid Biopsy Testing Can Improve Selection of Advanced Non-Small-Cell Lung Cancer Patients to Rechallenge with Gefitinib

scientific article published on 25 September 2019

Measuring tumor mutation burden in non-small cell lung cancer: tissue versus liquid biopsy

artículo científico publicado en 2018

Molecular diagnostics and personalized medicine in oncology: Challenges and opportunities

artículo científico publicado en 2013

Positron emission tomography and circulating tumor cells to monitor a dramatic response to gefitinib.

artículo científico publicado en 2012

Should epidermal growth factor receptor tyrosine kinase inhibitors be considered ideal drugs for the treatment of selected advanced non-small cell lung cancer patients?

artículo científico publicado en 2012

Targeted sequencing analysis of cell-free DNA from metastatic non-small-cell lung cancer patients: clinical and biological implications

scientific article published on 01 February 2020

The S492R EGFR ectodomain mutation is never detected in KRAS wild-type colorectal carcinoma before exposure to EGFR monoclonal antibodies

scientific article published on 23 September 2013

The role of circulating free DNA in the management of NSCLC

scientific article published on 29 November 2018

p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab.

artículo científico publicado en 2014

Lista de obras de Raffaella Pasquale

Activity of gefitinib in a non-small-cell lung cancer patient with both activating and resistance EGFR mutations

Assessment of high-sensitive methods for the detection of EGFR mutations in circulating free tumor DNA from NSCLC patients

BRAF V600E mutation in metastatic colorectal cancer: Methods of detection and correlation with clinical and pathologic features.

Comparison of the seleno-transcriptome expression between human non-cancerous mammary epithelial cells and two human breast cancer cell lines

Detection of EGFR mutations by TaqMan mutation detection assays powered by competitive allele-specific TaqMan PCR technology

EGFR mutations in lung cancer: from tissue testing to liquid biopsy

Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma.

Liquid Biopsy Testing Can Improve Selection of Advanced Non-Small-Cell Lung Cancer Patients to Rechallenge with Gefitinib

Measuring tumor mutation burden in non-small cell lung cancer: tissue versus liquid biopsy

Molecular diagnostics and personalized medicine in oncology: Challenges and opportunities

Positron emission tomography and circulating tumor cells to monitor a dramatic response to gefitinib.

Should epidermal growth factor receptor tyrosine kinase inhibitors be considered ideal drugs for the treatment of selected advanced non-small cell lung cancer patients?

Targeted sequencing analysis of cell-free DNA from metastatic non-small-cell lung cancer patients: clinical and biological implications

The S492R EGFR ectodomain mutation is never detected in KRAS wild-type colorectal carcinoma before exposure to EGFR monoclonal antibodies

The role of circulating free DNA in the management of NSCLC

p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab.